Related Experiment Video
Updated: May 8, 2026

A New Method for Inducing a Depression-Like Behavior in Rats
Published on: February 22, 2018
Ecological momentary interventions for depression: A systematic review and meta-analysis
Suet Ying Yuen1, Heidi Ka Ying Lo1, Joyce Xu Hao Jin1
1Department of Psychiatry, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong, Hong Kong.
Introduction:
Depression remains a prevalent condition with many individuals experiencing residual symptoms despite standard treatments. Ecological momentary interventions (EMIs) offer real-time, ecologically-valid microinterventions, yet their clinical utility and implementation challenges in depression remain underexplored.
Method:
A systematic search of six databases (inception to 25 July 2025) identified randomised controlled trials (RCTs) evaluating EMIs for depression. Pooled effect sizes assessed differences relative to comparator conditions.
Results:
Sixteen RCTs involving 1258 participants were included. EMIs significantly reduced depressive symptoms at posttest (Hedges' g = 0.57; 95% CI = 0.33-0.80; p < 0.001) and at follow-up ranging from 10 to 32 weeks (Hedges' g = 0.43). High heterogeneity reflected variability in EMI formats. EMIs also showed a statistically significant improvement in quality of life (Hedges' g = 0.44; 95% CI = 0.17-0.71; p < 0.01), supporting their broader impact beyond symptom reduction. Engagement averaged 64.91% (SD = 17.18), ranging 37.5%- 88.0%, with variation across reporting methods. Acceptability and usability ratings were consistently high. Intervention dosage and risk of bias were significant moderators of treatment efficacy. Subgroup analyses revealed greater benefits from EMIs incorporating psychoeducation and active practice, and fully-automated formats.
Conclusion:
The review highlights EMI efficacy in reducing depressive symptoms and improving quality of life, with intervention dosage and methodological rigor emerging as key moderating factors. Reporting engagement remains a challenge, and substantial heterogeneity underscores the need for refined trial designs to isolate the active EMI components to best optimise treatment outcomes in depression. Future studies should prioritise strategies strengthen methodological rigor and optimising user engagement. PROSPERO No. CRD420251105663.
More Related Videos
04:29Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Related Concept Videos
Long-term Depression
Long-term Depression
Calcium Ion Concentration Mechanism
If over time, all...
Depression: Overview
Antidepressant Drugs: MAOIs and Other Agents
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...